Novel AAV Capsids for Intravitreal Delivery: Identifying and Characterizing Novel AAV Variants in Non-Human Primates

被引：0
|
作者：
Guerin, Karen [1 ]
Geller, Scott [2 ]
Flannery, John G. [2 ]
Isacoff, Ehud [2 ]
Beltran, William A. [3 ]
Byrne, Leah C. [4 ]
Ozturk, Bilge E. [4 ]
Mozayeni, Cyrus [1 ]
机构：
[1] Vedere Bio II, R&D, Cambridge, MA USA
[2] Univ Calif Berkeley, Mol & Cell Biol, Berkeley, CA 94720 USA
[3] Univ Penn, Div Expt Retinal Therapies, Philadelphia, PA 19104 USA
[4] Univ Pittsburgh, Ophthalmol, Philadelphia, PA USA
来源：
MOLECULAR THERAPY | 2022年 / 30卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
1199
引用
收藏
页码：557 / 557
页数：1
相关论文
共 50 条
  • [31] Global CNS gene delivery and evasion of anti-AAV-neutralizing antibodies by intrathecal AAV administration in non-human primates
    Gray, S. J.
    Kalburgi, S. Nagabhushan
    McCown, T. J.
    Samulski, R. Jude
    GENE THERAPY, 2013, 20 (04) : 450 - 459
  • [32] Comparison of CNS Transduction by Different AAV Capsids in Mouse and Non-Human Primate
    Goulet, Martin
    Aubin, Justin
    Kells, Adrian P.
    Su, Qin
    Yuan, Shipeng
    Ramamoorthi, Kartik
    Kotin, Rob
    McLaughlin, James
    Gao, Guangping
    Sah, Dinah W. Y.
    MOLECULAR THERAPY, 2015, 23 : S37 - S37
  • [33] Erratum: Global CNS gene delivery and evasion of anti-AAV-neutralizing antibodies by intrathecal AAV administration in non-human primates
    S J Gray
    S Nagabhushan Kalburgi
    T J McCown
    R Jude Samulski
    Gene Therapy, 2013, 20 (4) : 465 - 465
  • [34] AAV9 biodistribution and expression in the PNS of Non-Human Primates
    Kagiava, A.
    Casy, W.
    Trygg, C.
    Braun, S. E.
    Gray, S. J.
    Kleopa, K. A.
    HUMAN GENE THERAPY, 2022, 33 (23-24) : A37 - A37
  • [35] Safety and efficacy of AAV5-hFIX in non-human primates
    Nijmeijer, Bart
    Petry, Harald
    Spronck, Lisa
    van der Kruijssen, Corina
    Salmon, Florence
    HUMAN GENE THERAPY, 2014, 25 (11) : A38 - A38
  • [36] Evaluation of AAV variants for improved transgene expression after intravitreous injection in rodents and non-human primates
    Keravala, A.
    Ni, M.
    Todorov, G.
    Vijay, S.
    Kniffin, T.
    Gasmi, M.
    Woodburn, K.
    Chalberg, T. W.
    HUMAN GENE THERAPY, 2015, 26 (10) : A100 - A100
  • [37] Biodistribution and Safety Study of AAV9 in Non-Human Primates
    Lostal, William
    Roudaut, Carinne
    Deschamps, Jack-Yves
    Richard, Isabelle
    MOLECULAR THERAPY, 2018, 26 (05) : 190 - 190
  • [38] Rationally engineered novel AAV capsids for intra-articular gene delivery
    Li, Wenjun
    Feng, Susi Liu
    Herrschaft, Lizette
    Samulski, R. Jude
    Li, Chengwen
    MOLECULAR THERAPY METHODS & CLINICAL DEVELOPMENT, 2024, 32 (01)
  • [39] Comparable efficiency of photoreceptor transduction by AAV2tYF, AAV5 and AAV8 in non-human primates
    Shearman, M. S.
    Song, C. J.
    Ye, G.
    Timmers, A. M.
    Newmark, J.
    HUMAN GENE THERAPY, 2018, 29 (12) : A153 - A153
  • [40] Optimizing Intravitreal Delivery to the Non-Human Primate Retina with Machine-Guided AAV Capsid Design
    Abesteh, Shireen
    Brenckle, Ian
    Cargill, Zac
    Chen, Ina
    Chen, Sam
    Deny, Daniela
    Fathima, Jumana
    Gerold, Jeff
    Ghosh, Arpan
    Grush, Jacob
    Kelsic, Eric
    Kuchwara, Helene Marie
    Kwasnieski, Jamie
    Lin, Kathy S.
    Lykken, Erik A.
    Marrogi, Eryney
    Maryak, Katie
    McDonel, Patrick
    Levitin, Hanna Mendes
    Miles, Amanda
    Nagabhushana, Nishith
    Pignatta, Daniela
    Satinsky, Brandon
    Saxena, Bhavica
    Sengel, Cem
    Sheridan, Abigail Rose
    Tarbell, Timothy
    Thommes, Meghan
    Turunen, Heikki
    White, Nick
    Wolock, Sam
    MOLECULAR THERAPY, 2023, 31 (04) : 610 - 610
12345